Telemus Capital’s Immunomedics Inc IMMU Stock Holding History

Telemus Capital’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,531	Closed	-$435K	–	442
2020 Q2	$435K	Hold	10,531	–	–	0.03%	296
2020 Q1	$354K	Buy	+10,531	New	+$177K	0.03%	290

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Telemus Capital's IMMU Position: Q3 2020 in Review

Telemus Capital sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 10,531 shares — an estimated $435K sold.

Telemus Capital first reported a position in IMMU in Q1 2020 and held it in 2 quarters. The position peaked at $435K in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

Telemus Capital reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
Telemus Capital sold 10,531 Immunomedics Inc shares in Q3 2020, an estimated $435K.
Telemus Capital first reported a position in Immunomedics Inc in Q1 2020 and held it in 2 quarters.
Telemus Capital's Immunomedics Inc position peaked at $435K in Q2 2020.
408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Telemus Capital's 13F filing for Q3 2020, filed 2 Nov 2020.